A REVIEW OF SODIUM PENTOBARBITAL (NAP)

pentobarbital decreases effects of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Carefully. Coadministration of CYP3A4 inducers may possibly reduce sufentanil ranges and efficacy, maybe precipitating withdrawal syndrome in patients that have designed Actual physical dependence to sufentanil. Disconti